Catherine M. Brenner
Villejuif, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
A plasma proteomic signature of cancer-related sarcopenia implicates the IGFBP axis in muscle dysfunction.
Journal: Molecular cancer
Published: February 15, 2026
Inhibition of TRAP1 in the C-terminal domain influences mitochondria properties and breast cancer cell metabolism.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 23, 2025
Enhanced Expression of IL32 mRNA in Skeletal Muscles in the Context of Head and Neck Carcinomas.
Journal: Journal of cachexia, sarcopenia and muscle
Published: March 19, 2025
Apoptosis-inducing factor (AIF) at the crossroad of cell survival and cell death: implications for cancer and mitochondrial diseases.
Journal: Cell communication and signaling : CCS
Published: March 17, 2025
GATOR1 complex controls cisplatin sensitivity.
Journal: Cell death & disease
Published: March 13, 2025
The pro-apoptotic peptide PEP-010 triggers apoptosis in pancreatic tumor models in monotherapy and in combination with gemcitabine independently of the KRAS status.
Journal: Cancer letters
Published: January 28, 2025
C-terminal binding protein-2 triggers CYR61-induced metastatic dissemination of osteosarcoma in a non-hypoxic microenvironment.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 02, 2024
The first-in-class pro-apoptotic peptide PEP-010 is effective in monotherapy and in combination with paclitaxel on resistant ovarian adenocarcinoma cell models.
Journal: Frontiers in pharmacology
Published: June 06, 2024
A translational study for biomarker identification of PEP-010, a pro-apoptotic peptide restoring apoptosis in cancer models.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: March 18, 2024
Apoptotic cell death in disease-Current understanding of the NCCD 2023.
Journal: Cell death and differentiation
Published: January 30, 2023
Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors.
Journal: Oncoimmunology
Published: December 22, 2022
Last Updated: 09/26/2026